NCAM1 and COVID-19: Previous studies indicated that SARS-CoV-2 infections could lead to dysregulation of the levels of lymphocyte subsets, by showing that the absolute counts of CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, and CD56+ NK cells were reduced in patients with COVID-19 [2, 5].